Trends in scientific production related to health economy in Colombia
DOI:
https://doi.org/10.22458/caes.v16i1.5817Keywords:
Health Economics, Economics and Health Care Organizations, Bibliometrics, VOSviewer, ScopusAbstract
Around the world, health systems have prioritized improving the performance and quality of health services through targeted public policies. This has generated the need to reform existing healthcare models in order to improve management and focus on creating healthcare systems that are high quality, safe and efficient. This study aims to summarize the literature related to Health Economics in Colombia through a bibliometric analysis. 103 documents on the subject extracted from Scopus were examined, and indicators were created to identify the progress of scientific creation, the most relevant journals, authors and organizations, the countries with the greatest production, the bibliographic coupling networks, the most relevant terms. used and future lines of research.
The results revealed that publications have been occurring since 1975, peaking in 2023. Additionally, 5 clusters were identified that can guide future research by recognizing emerging scientific trends.
References
Alvis-Guzman, N., Orozco-Africano, J., Paternina-Caicedo, A., Coronell-Rodríguez, W., Alvis-Estrada, L., Jervis-Jálabe, D., & De la Hoz-Restrepo, F. (2013). Treatment costs of diarrheal disease and all-cause pneumonia among children under-5 years of age in Colombia. Vaccine, 31(SUPPL.3), C58-C62. https://doi.org/10.1016/j.vaccine.2013.05.035
Antonio, B., Patiño, D., & Moreno, M. (2022). Cost-utility analysis and budget impact of benralizumab as add-on therapy to standard care for severe eosinophilic asthma in Colombia. EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 22(2), 299-305. https://doi.org/10.1080/14737167.2021.1945445
Antonio Buendía, J., & Patiño, D. G. (2022). Cost-utility analysis of dupilumab add on therapy versus standard therapy in adolescents and adults for severe asthma in Colombia. Expert Review of Pharmacoeconomics and Outcomes Research, 22(4), 575-580. https://doi.org/10.1080/14737167.2022.2011217
Augustovski, F., Iglesias, C., Manca, A., Drummond, M., Rubinstein, A., & Martí, S. G. (2009). Barriers to generalizability of health economic evaluations in Latin America and the Caribbean region. PharmacoEconomics, 27(11), 919-929. https://doi.org/10.2165/11313670-000000000-00000
Boeris, C. (2010). Aplicación de métodos bibliométricos a la evaluación de colecciones: El caso de la Biblioteca del Instituto Argentino de Radioastronomía. [Universidad Nacional de la Plata]. https://www.memoria.fahce.unlp.edu.ar/tesis/te.371/te.371.pdf
Bonilla, C. A., Merigó, J. M., & Torres-Abad, C. (2015). Economics in Latin America: A bibliometric analysis. Scientometrics, 105(2), 1239-1252. https://doi.org/10.1007/s11192-015-1747-7
Borrajo, G. J. C. (2007). Newborn screening in Latin America at the beginning of the 21st century. J. Inherit. Metab. Dis., 30(4), 466-481. https://doi.org/10.1007/s10545-007-0669-9
Buendia, J. A., Acuña-Cordero, R., & Rodriguez-Martinez, C. E. (2020). The cost-utility of intravenous magnesium sulfate for treating asthma exacerbations in children. Pediatric Pulmonology, 55(10), 2610-2616. https://doi.org/10.1002/ppul.25024
Buendía, J. A., Acuña-Cordero, R., & Rodriguez-Martinez, C. E. (2021a). Cost utility of fractional exhaled nitric oxide monitoring for the management of children asthma. Cost Effectiveness and Resource Allocation, 19(1). https://doi.org/10.1186/s12962-021-00287-3
Buendía, J. A., Acuña-Cordero, R., & Rodriguez-Martinez, C. E. (2021b). The cost-utility of early use of high-flow nasal cannula in bronchiolitis. Health Economics Review, 11(1). https://doi.org/10.1186/s13561-021-00339-7
Buendía, J. A., Lindarte, E. F., & Guerrero Patiño, D. (2023). Phosphodiesterase 5 Inhibitor for Pediatric Pulmonary Arterial Hypertension: A Cost-Utility Analysis. Value in Health Regional Issues, 36, 44-50. https://doi.org/10.1016/j.vhri.2023.02.001
Buendia, J. A., Patino, D. G., & Lindarte, E. F. (2023). Cost-utility of ambrisentan and bosentan for pediatric pulmonary arterial hypertension. Expert Review of Pharmacoeconomics and Outcomes Research, 23(8), 967-973. https://doi.org/10.1080/14737167.2023.2233698
Buendía, J. A., & Patiño, D. G. (2021). Costs of Respiratory Syncytial Virus Hospitalizations in Colombia. PharmacoEconomics - Open, 5(1), 71-76. https://doi.org/10.1007/s41669-020-00218-7
Buendía, J. A., & Patiño, D. G. (2023a). Corticosteroids for the treatment of respiratory infection by Mycoplasma pneumoniae in children: A cost-utility analysis. Pediatric Pulmonology, 58(10), 2809-2814. https://doi.org/10.1002/ppul.26592
Buendía, J. A., & Patiño, D. G. (2023b). Cost-utility of vitamin D supplementation to prevent acute respiratory infections in children. Cost Effectiveness and Resource Allocation, 21(1). https://doi.org/10.1186/s12962-023-00433-z
Castro-Rodriguez, J. A., Forno, E., Rodriguez-Martinez, C. E., & Celedón, J. C. (2016). Risk and Protective Factors for Childhood Asthma: What Is the Evidence? The Journal of Allergy and Clinical Immunology: In Practice, 4(6), 1111-1122. https://doi.org/10.1016/j.jaip.2016.05.003
Chew, C., & Eysenbach, G. (2010). Pandemics in the Age of Twitter: Content Analysis of Tweets during the 2009 H1N1 Outbreak. PLoS ONE, 5(11), e14118. https://doi.org/10.1371/journal.pone.0014118
de Oliveira Avellar, W., Ferreira, É. A., Vieira, A. C. R. A., de Melo, A. C., & Aran, V. (2023). Clinical Cancer Research in South America and Potential Health Economic Impacts. Healthcare (Switzerland), 11(12). https://doi.org/10.3390/healthcare11121753
Fajardo, R., Valenzuela, J. I., Olaya, S. C., Quintero, G., Carrasquilla, G., Pinzón, C. E., López, C., & Ramírez, J. C. (2011). Costo-efectividad de la colecistectomía laparoscópica y de la abierta en una muestra de población colombiana. Biomédica, 31(4), 514. https://doi.org/10.7705/biomedica.v31i4.405
Feigin, V. L., Stark, B. A., Johnson, C. O., Roth, G. A., Bisignano, C., Abady, G. G., Abbasifard, M., Abbasi-Kangevari, M., Abd-Allah, F., Abedi, V., Abualhasan, A., Abu-Rmeileh, N. M., Abushouk, A. I., Adebayo, O. M., Agarwal, G., Agasthi, P., Ahinkorah, B. O., Ahmad, S., Ahmadi, S., … Murray, C. J. L. (2021). Global, regional, and national burden of stroke and its risk factors, 1990–2019: A systematic analysis for the Global Burden of Disease Study 2019. The Lancet Neurology, 20(10), 795-820. https://doi.org/10.1016/S1474-4422(21)00252-0
Garcia, P. J., Alarcón, A., Bayer, A., Buss, P., Guerra, G., Ribeiro, H., Rojas, K., Saenz, R., de Snyder, N. S., Solimano, G., Torres, R., Tobar, S., Tuesca, R., Vargas, G., & Atun, R. (2020). COVID-19 Response in Latin America. American Journal of Tropical Medicine and Hygiene, 103(5), 1765-1772. https://doi.org/10.4269/ajtmh.20-0765
Global Burden of Disease 2019 Cancer Collaboration. (2022). Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019: A Systematic Analysis for the Global Burden of Disease Study 2019. JAMA Oncology, 8(3), 420-444. https://doi.org/10.1001/jamaoncol.2021.6987
Goldie, S. J., Diaz, M., Constenla, D., Alvis, N., Andrus, J. K., & Kim, S.-Y. (2008). Mathematical Models of Cervical Cancer Prevention in Latin America and the Caribbean. Vaccine, 26(SUPPL. 11), L59-L72. https://doi.org/10.1016/j.vaccine.2008.05.063
Grassi, B., Gómez, A. M., Calliari, L. E., Franco, D., Raggio, M., Riera, F., Castro, M., McVean, J., van den Heuvel, T., Arrieta, A., Castañeda, J., & Cohen, O. (2023). Real-world performance of the MiniMed 780G advanced hybrid closed loop system in Latin America: Substantial improvement in glycaemic control with each technology iteration of the MiniMed automated insulin delivery system. Diabetes, Obesity and Metabolism, 25(6), 1688-1697. https://doi.org/10.1111/dom.15023
Hill II, G. J. (1975). Outpatient surgery-what are the indications for it? Surgery, 77(3), 333-335.
Iglesias, C. P., Drummond, M. F., & Rovira, J. (2005). Health-care decision-making processes in Latin America: Problems and prospects for the use of economic evaluation. International Journal of Technology Assessment in Health Care, 21(1), 1-14. https://doi.org/10.1017/S0266462305050014
Machado, M., Iskedjian, M., & Einarson, T. R. (2006). Quality assessment of published health economic analyses from South America. Annals of Pharmacotherapy, 40(5), 943-949. https://doi.org/10.1345/aph.1G296
Melo-Becerra, L. A., Arango-Thomas, L. E., Ávila-Montealegre, Ó., Ayala-García, J., Bonilla-Mejía, L., Botero-García, J. A., Cardona-Badillo, M., Crispin-Fory, C., Gallo-Montaño, D. D. P., Granger-Castaño, C. J., Guzmán-Finol, K., Iregui-Bohórquez, A. M., Ospina-Tejeiro, J. J., Pinilla-Alarcón, D., Posso-Suárez, C., Ramírez-Giraldo, M. T., Ramos-Forero, J. E., Ramos-Veloza, M., Restrepo-Tobón, D. A., … Vásquez-Escobar, D. M. (2023). Aspectos financieros y fiscales del sistema de salud en Colombia. Ensayos sobre Política Económica, 106, 1-92. https://doi.org/10.32468/espe106
Mendoza, N. M., Cucunubá, Z. M., Aponte, S., Gonzalez, N. E., & Bernal, S. D. (2013). Evaluación de campo de la precisión diagnóstica de la prueba de diagnóstico rápido SD Bioline Malaria Antigen Pf/Pv® en Colombia. Biomédica, 33(4). https://doi.org/10.7705/biomedica.v33i4.1464
Morales, A., Martinez, M. M., Tasset-Tisseau, A., Rey, E., Baron-Papillon, F., & Follet, A. (2004). Costs and benefits of influenza vaccination and work productivity in a Colombian company from the employer’s perspective. Value in Health, 7(4), 433-441. https://doi.org/10.1111/j.1524-4733.2004.74006.x
Muñoz, N., Franco, E. L., Herrero, R., Andrus, J. K., de Quadros, C., Goldie, S. J., & Bosch, F. X. (2008). Recommendations for Cervical Cancer Prevention in Latin America and the Caribbean. Vaccine, 26(SUPPL. 11), L96-L107. https://doi.org/10.1016/j.vaccine.2008.05.062
Murphy, A., Palafox, B., Walli-Attaei, M., Powell-Jackson, T., Rangarajan, S., Alhabib, K. F., Avezum, A. J., Calik, K. B. T., Chifamba, J., Choudhury, T., Dagenais, G., Dans, A. L., Gupta, R., Iqbal, R., Kaur, M., Kelishadi, R., Khatib, R., Kruger, I. M., Kutty, V. R., … McKee, M. (2020). The household economic burden of non-communicable diseases in 18 countries. BMJ Global Health, 5(2). https://doi.org/10.1136/bmjgh-2019-002040
Pichon-Riviere, A., Elias, F. T. S., Rivero, V. G., & Vaca, C. P. (2012). Early awareness and alert activities in Latin America: Current situation in four countries. International Journal of Technology Assessment in Health Care, 28(3), 315-320. https://doi.org/10.1017/S0266462312000311
Rodriguez-Martinez, C. E., Sossa-Briceño, M. P., & Castro-Rodriguez, J. A. (2019). Cost-effectiveness of the utilization of “good practice” or the lack thereof according to a bronchiolitis evidence-based clinical practice guideline. Journal of Evaluation in Clinical Practice, 25(4), 682-688. https://doi.org/10.1111/jep.13157
Rodriguez-Martinez, C. E., Sossa-Briceño, M. P., & Castro-Rodriguez, J. A. (2020a). Advantage of inhaled corticosteroids as additional therapy to systemic corticosteroids for pediatric acute asthma exacerbations: A cost-effectiveness analysis. Journal of Asthma, 57(9), 949-958. https://doi.org/10.1080/02770903.2019.1628254
Rodriguez-Martinez, C. E., Sossa-Briceño, M. P., & Castro-Rodriguez, J. A. (2020b). Direct medical costs of pediatric asthma exacerbations requiring hospital attendance in a middle-income country. Allergologia et Immunopathologia, 48(2), 142-148. https://doi.org/10.1016/j.aller.2019.06.015
Van Eck, N. J., & Waltman, L. (2014). Visualizing Bibliometric Networks. En Y. Ding, R. Rousseau, & D. Wolfram (Eds.), Measuring Scholarly Impact (pp. 285-320). Springer International Publishing. https://doi.org/10.1007/978-3-319-10377-8_13
Van Eck, N. J., & Waltman, L. (2019). VOSviewer Manual. Leiden University. https://www.vosviewer.com/documentation/Manual_VOSviewer_1.6.10.pdf
Vences Pérez, S., Díaz-Larrea, J., Cruz-Aviña, J. R., & Cabrera, R. (2022). Análisis bibliométrico de Dermochelys coriacea en México utilizando Vosviewer y Scopus. Nexo Revista Científica, 35(02), 448-458. https://doi.org/10.5377/nexo.v35i02.14622
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Revista Electrónica Calidad en la Educación Superior
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Esta revista provee acceso libre inmediato a su contenido bajo el principio de que hacer disponible gratuitamente la investigación al publico, lo cual fomenta un mayor intercambio de conocimiento global.
